ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2021

Activation of FGFR2 Signaling Suppresses BRCA1 and Drives Triple-Negative Mammary Tumorigenesis That is Sensitive to Immunotherapy.

Josh Haipeng Lei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.